Catharine Wang
Profiles

Catharine Wang, PhD

Associate Professor, Community Health Sciences - Boston University School of Public Health

clwang@bu.edu

Biography

Dr. Wang is an Associate Professor in the Community Health Sciences Department, and a Peter T. Paul Career Development Professor, at Boston University. She obtained her doctorate in Health Behavior and Health Education from the University of Michigan and has expertise in mixed-methods research, intervention development, and program evaluation. Her research has spanned across several areas including health communication/digital health, health literacy, public health genomics, and cancer care implementation and delivery. Dr. Wang currently serves as a member of the National Cancer Institute's PDQ Cancer Genetics Editorial Board.

Dr. Wang has over 20 years of experience in studying the ethical, legal, and social implications (ELSI) of genomic advances. Her work exemplifies her commitment to mitigating health disparities via accessible information, interventions, and services. Dr. Wang has been the Principal Investigator on multiple grants examining various ELSI topic areas including (a) communication of genetic risk, (b) barriers to genetic literacy among underserved populations, and (c) adoption and use of genetic testing. Her ongoing research continues to examine how underrepresented and vulnerable populations comprehend and engage with population-based efforts to facilitate greater access to genetic information and services.

Dr. Wang currently teaches SB821: Intervention Strategies for Health Promotion.

Other Positions

  • Member, BU-BMC Cancer Center - Boston University
  • Member, Genome Science Institute - Boston University

Education

  • University of Michigan at Ann Arbor, PhD Field of Study: Social & Behavioral Sciences
  • University Waterloo, MSc Field of Study: Social & Behavioral Sciences

Classes Taught

  • SPHSB821

Publications

  • Published on 1/9/2024

    Wagner IM, Xuan Z, Lu H, Wang C. Racial Disparities in Accessing Care along the Continuum of Cancer Genetic Service Delivery. Cancer Epidemiol Biomarkers Prev. 2024 Jan 09; 33(1):55-62. PMID: 37819271.

    Read At: PubMed
  • Published on 12/5/2023

    Delgado IS, Outterson A, Ramesh V, Amador Sanchez AG, Boza AC, Lopez-Pilarte D, Amador Velázquez JJ, Friedman DJ, Brooks DR, Scammell MK, Wang C. Ethical considerations for genetic research in low-income countries: perceptions of informed consent, data sharing, and expectations in Nicaragua. Eur J Hum Genet. 2023 Dec 05. PMID: 38052907.

    Read At: PubMed
  • Published on 7/27/2023

    Wang C, Bertrand KA, Trevino-Talbot M, Flynn M, Ruderman M, Cabral HJ, Bowen DJ, Hughes-Halbert C, Palmer JR. Ethical, legal, and social implications (ELSI) and challenges in the design of a randomized controlled trial to test the online return of cancer genetic research results to U.S. Black women. Contemp Clin Trials. 2023 Sep; 132:107309. PMID: 37516165.

    Read At: PubMed
  • Published on 6/29/2023

    Gunn CM, Gignac G, Hardy B, Zayhowski K, Pankowska M, Loo S, Wang C. Characterizing Referrals for Prostate Cancer Genetic Services in a Safety-Net Hospital. JCO Oncol Pract. 2023 Oct; 19(10):852-859. PMID: 37384869.

    Read At: PubMed
  • Published on 2/11/2023

    Wang C, Lu H, Bowen DJ, Xuan Z. Implementing digital systems to facilitate genetic testing for hereditary cancer syndromes: An observational study of 4 clinical workflows. Genet Med. 2023 May; 25(5):100802. PMID: 36906849.

    Read At: PubMed
  • Published on 1/1/2023

    Gunn CM, Li EX, Gignac GA, Pankowska M, Loo S, Zayhowski K, Wang C. Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care. Cancer Control. 2023; 30:10732748221143884. PMID: 36946278.

    Read At: PubMed
  • Published on 11/1/2022

    Dusic EJ, Theoryn T, Wang C, Swisher EM, Bowen DJ. Barriers, interventions, and recommendations: Improving the genetic testing landscape. Front Digit Health. 2022; 4:961128. PMID: 36386046.

    Read At: PubMed
  • Published on 5/10/2022

    Dusic EJ, Bowen DJ, Bennett R, Cain KC, Theoryn T, Velasquez M, Swisher E, Brant JM, Shirts B, Wang C. Socioeconomic Status and Interest in Genetic Testing in a US-Based Sample. Healthcare (Basel). 2022 May 10; 10(5). PMID: 35628017.

    Read At: PubMed
  • Published on 5/1/2022

    Ellison J, Wang C, Yarrington C, Connors P, Hanchate A. Insurance and geographic variations in non-invasive prenatal testing. Prenat Diagn. 2022 Jul; 42(8):1004-1007. PMID: 35484945.

    Read At: PubMed
  • Published on 8/23/2021

    Henderson V, Ganschow P, Wang C, Hoskins KF. Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken? Cancer. 2022 01 01; 128(1):30-33. PMID: 34424551.

    Read At: PubMed

News & In the Media